Skip to main content

This job has expired

You will need to login before you can apply for a job.

Sr Scientist, Target Information Group

Regeneron Pharmaceuticals, Inc.
Tarrytown, New York
Start date
Mar 23, 2023

Job Details

The Target Identification Group is a team of specialty scientists that collaborate with Therapeutic Focus Areas to identify new drug targets, technologies and provide in depth analysis of various disease mechanisms. We are seeking a motivated, curious, and communicative scientist with experience in immunology and infectious diseases to support company’s investigations of new antibody and technology-based therapies. In this role, the ideal candidate will utilize their expertise to evaluate protein targets- gene expression, protein structure/function, and biological/medical relevance. Investigations include searching of the scientific literature and proprietary databases, mining of large data sets directed to understanding the molecular basis of human disease.


As a Senior Scientist, a typical day might include:

  • Reviewing and identifying targets, opportunities, and potential strategies for drug development

  • Participating in complex biological evaluations, detailed genomic database and literature reviews

  • Preparing and presenting summaries, and recommendations to research teams and management

  • Delivering in a timely fashion, a balanced synopsis for each topic which may require consultations with subject-matter experts

  • Contributing to knowledge base resources and facilitate sharing and leveraging of program review information

This role might be for you if:

  • You have good communication skills to deliver concise summaries on a range of topics

  • You possess strong interpersonal skills

  • You have a flexible mindset in tackling new tasks and can quickly establish credibility

  • You have an interest to mine gene, protein, patent and proprietary databases


To be considered for this role, you must possess a Ph.D. or Pharm.D. A background in immunology and/or infectious disease is required. A minimum of three (3) years postdoctoral experience is highly desirable. Strong publication record is a big plus. Experience working with cross-functional teams; Database mining/ bioinformatics; Antibody/ recombinant protein therapeutics experience is required. You must have the ability to identify key information sources and analyze public literature.

Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides comprehensive benefits including health and wellness programs, fitness centers and equity awards, annual bonuses, and paid time off for eligible employees at all levels!

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.

The salary ranges provided are shown in accordance with U.S. law and apply to U.S. based positions, where the hired candidate will be located in the U.S. If you are outside the U.S, please speak with your recruiter about salaries and benefits in your location.

Salary Range (annually)

$103,600.00 - $169,000.00


Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Corporate Headquarters
777 Old Saw Mill River Road
New York

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert